|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Empagliflozin as add-on to metformin in patients with type 2 diabetes: a 24- week, randomized, double-blind, placebo-controlled trial显示文摘 | Haring HU Merker L Seewaldt-Becker E | 2014 | Diabetes Care2014，37，6： | 1 |
| 2 | Living systems theory:A framework for management显示文摘 | Merker S L | 1985 | Behavioral Science1985，30，： | 1 |
| 3 | Management of proximal deep vein thrombosis显示文摘 | Nyamekye I Merker L | 2012 | Phlebology2012，27，2： | 1 |
| 4 | Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double- blind, placebo-controlled trial显示文摘 | Hating HU Merker L Seewaldt-Becker E | 2013 | Diabetes Care2013，36，11： | 1 |
| 5 | Empagliflozin as add-on to metformin in patients with type 2 diabetes : a 24-week, randomized, double-blind, placebo-controlled trial显示文摘 | Haring H-U Merker L | 2014 | Diabetes Care2014，37，6： | 1 |
| 6 | Empagliflozin as add-on to meffonnin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized,double-blind, placebo-controlled trial 显示文摘 | Hating H-U Merker L | 2013 | Diabetes Care2013，36，11： | 1 |
| 7 | Management of proximal deep vein throm-bosis显示文摘 | Nyamekye I Merker L | 2012 | Phlebology2012，272，： | 1 |
| 8 | Management of proximal deep vein throm-bosis显示文摘 | Nyamekye I Merker L | 2012 | Phlebology2012，272，： | 1 |
| 9 | Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing显示文摘 | Boyd S D Marshall E L Merker J D | 2009 | Sci Transl Med2009，1，12： | 1 |
| 10 | Safety,tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naive patients with type 2 diabetes:a double-blind extension of a Phase 111 randomized controlled trial显示文摘 | Roden M Merker L Christiansen AV | 2015 | Cardiovasc Diabetol2015，14，： | 1 |
| 11 | Empa- gliflozin as add-on to metformin inpatients with type 2 dia- betes: a 24-week, randomized, double-blind, placebo- controlled trial显示文摘 | H/iring HU Merker L Seewaldt-BeckerE | 2014 | Diabetes2014，37，6： | 1 |
| 12 | The Reaction of alkyl halides with carboxylic acids and phenols in the presence of tertiary amines显示文摘 | SCOTT M J | 1961 | J Org Chem1961，26，12： | 1 |
| 13 | Em- pagliflozin as add-on to metformiu plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, pla- cebocontrolled trial显示文摘 | H~RING HU MERKER L SEEWALDT-BECKER E | 2013 | Diabetes Care2013，36，11： | 1 |
| 14 | Efficacy and Safety of Empagliflozin (EMPA) in Younger, Overweight/Obese Patients with Type 2 Diabetes ( T2DM ) with HbAlc > 8%显示文摘 | Merker L Lund SS Hantel S | | Diabetologie Und Stoffwechsel0，10，01： | 1 |
| 15 | Cyanide Increases Reduction But Decreases Sequestration of Methylene Blue by Endothelial Cells 显示文摘 | Olson L E Merker M P Patel M K | 2000 | Ann Biomed Eng2000，28，1： | 1 |
| 16 | Influence of fruit variety, harvest technique, quality sorring, and storage on the native microflora of unpasteurized apple cider 显示文摘 | KELLER S E CHIRTEL S J MERKER R I TAYLOR K T TAN H L | 2004 | Journal of Food Protection2004，67，10： | 1 |
| 17 | A study of solution polymerization of polyphosphazenes显示文摘 | Mujumdar A N Young S G Merker R L | 1990 | Macromolecules1990，23，1： | 1 |
| 18 | STAT3 mutations are fre- quent in CD30 + T-cell lymphomas and T-cell large granular lym- phocytic leukemia显示文摘 | Ohgami RS Ma L Merker JD et at | 2013 | Leukemia2013，27，11： | 1 |
| 19 | Management of, proximal deep veinthrombosis 显示文摘 | Nyamekye I Merker L | 2012 | Phlebology2012，27，2： | 1 |
| 20 | Living systems theory:A framework for management显示文摘 | Merker S L | 1985 | Behavioral Science1985，30，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员